GENIL PEER ANALYSIS

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi — metric-by-metric comparison with peers and the industry median

GENILGen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

GENILIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	GENIL	AMPH	PCRX	IRWD	BHC	PAHC	Ind. Median
P/E	46.82	11.77	205.59	7.29●	—	14.27	21.55
P/B	3.47	1.21	1.62	-3.43●	-0.89	3.76	1.91
EV/EBITDA	14.07	6.92	10.69	5.42	4.05●	9.18	12.18
P/S	1.86	1.29	1.44	2.06	0.21●	0.91	2.13

Financial Health
Metric	GENIL	AMPH	PCRX	IRWD	BHC	PAHC	Ind. Median
Current Ratio	1.33	3.85	4.73●	1.41	1.32	3.17	2.22
Debt/Equity	41.0%	88.7%	62.9%	-275.1%	-1,010.0%●	217.6%	46.3%
NetDebt/EBITDA	1.10●	2.05	1.77	1.82	3.71	3.15	1.24

Profitability
Metric	GENIL	AMPH	PCRX	IRWD	BHC	PAHC	Ind. Median
Net Margin	4.0%	11.0%	0.7%	28.3%●	-13.5%	6.3%	4.0%
ROE	8.7%	10.4%	0.7%	—	—	30.3%●	6.4%
ROA	4.8%	4.8%	0.4%	26.8%●	-4.7%	6.9%	3.4%
EBITDA Margin	14.3%	26.6%	16.1%	57.3%	60.0%●	15.0%	18.2%

Growth + Dividend
Metric	GENIL	AMPH	PCRX	IRWD	BHC	PAHC	Ind. Median
Rev. Growth	16.3%	-1.1%	4.6%	13.8%	-9.9%	26.0%●	7.5%
NI Growth	146.6%	-44.1%	—	—	—	199.6%●	5.0%
Div. Yield	0.0%	—	—	—	0.0%	1.5%●	2.0%
Payout	0.0%	—	—	—	0.0%	20.4%	0.8%

Valuation
Metric	GENIL	ECILC	DEVA	Ind. Median
P/E	46.82	—	—	21.55
P/B	3.47	0.77	0.49●	1.91
EV/EBITDA	14.07	32.83	6.51●	12.18
P/S	1.86	4.88	0.68●	2.13

Financial Health
Metric	GENIL	ECILC	DEVA	Ind. Median
Current Ratio	1.33	1.73	2.00●	2.22
Debt/Equity	41.0%	5.9%●	23.1%	46.3%
NetDebt/EBITDA	1.10	-0.10●	0.89	1.24

Profitability
Metric	GENIL	ECILC	DEVA	Ind. Median
Net Margin	4.0%●	-3.6%	-4.4%	4.0%
ROE	8.7%●	-0.6%	-3.6%	6.4%
ROA	4.8%●	-0.5%	-2.5%	3.4%
EBITDA Margin	14.3%	14.8%●	12.0%	18.2%

Growth + Dividend
Metric	GENIL	ECILC	DEVA	Ind. Median
Rev. Growth	16.3%●	-2.3%	7.7%	7.5%
NI Growth	146.6%	—	—	5.0%
Div. Yield	0.0%	2.7%●	0.0%	2.0%
Payout	0.0%	-365.1%	0.0%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GENIL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.